As of 9:30 AM on the 10th, Seegene is trading at 310,300 KRW, down 0.61% from the previous day. This represents an 86.48% increase compared to July 15. Seegene is known as a company that develops, manufactures, and sells molecular diagnostic reagents.

Over the past five days, individual investors have net purchased 438,886 shares, while foreigners and institutions have net sold 365,755 shares and 70,452 shares, respectively.

On August 6, Seegene became a market topic with the headline "New High on Q2 Earnings Expectations."

※Source: AI Investment Assistant AI Rasero

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing